Create your Personal Health Record and unlock support built around you
- Treatments and trials you qualify for
- Education for your stage of care
- Financial support for your medications
- Solutions to your side effects
CELMoDs: Boosting T-Cell Therapies with Iberdomide & Mezigdomide | Joshua Richter, MD| #IMS2025
HealthTreeDescription
Dr. Joshua Richter explains how new CELMoDs, Iberdomide and Mezigdomide, enhance T-cell therapies like bispecifics and CAR-T, offering powerful new options for myeloma treatment.
Watch the full course and our most up-to-date content here: https://linktr.ee/HealthTreeUniversity
Create a free account to track your progress, bookmark lessons, and keep up-to-date on the latest advancements in treating cancer!
Patients have the key to find cures for cancer. Learn more about HealthTree Cure Hub here: https://healthtree.org/curehub?utm_source=social+media&utm_medium=htu+youtube&utm_campaign=htu-curehub&utm_content=general
Educated and empowered patients have better outcomes. We've partnered with hundreds of medical experts and doctors to help you learn more about your disease.